IMMUNITYBIO, INC. Intangible Assets, Net (Excluding Goodwill)
IMMUNITYBIO, INC. (IBRX) had Intangible Assets, Net (Excluding Goodwill) of $16.06 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2024-08-12
- 2024-06-30: Intangible Assets, Net (Excluding Goodwill) $16.06M.
- 2024-03-31: Intangible Assets, Net (Excluding Goodwill) $16.57M.
- 2023-12-31: Intangible Assets, Net (Excluding Goodwill) $17.09M.
- 2023-09-30: Intangible Assets, Net (Excluding Goodwill) $18.47M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2024-06-30 | $16.06M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $16.57M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $17.09M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | $18.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.99M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $19.50M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $20.00M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $20.47M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $21.74M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $22.35M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.42M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $1.43M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.44M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $12.07M 8-K/A · filed 2021-04-22 | $0.00 10-K · filed 2020-03-25 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $565.00K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.13M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.70M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.26M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $2.83M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $3.39M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $3.96M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.52M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $5.09M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $5.95M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.40M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.84M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $7.29M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $7.16M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $7.62M 10-Q · filed 2015-09-10 | |
| 2014-12-31 | $835.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |